I just have, and page 13 as well. To be honest there is only two things I can pick up as new.
As thrasher pointed out:-
3. Tumour-targeting (~70x more)
So, what does that mean? Anyone?
Page 13 also mentions at the top:-
Phase 1 Clinical Trial (open label study - 25-30 cancer patients - various solid tumours)
So I assume those extra numbers that ajk92 picked up on are for phase 2.
The SP has done absolutely nothing on this presentation and I'm not surprised.
Again I say, what about DEP DOX!?
I just have, and page 13 as well. To be honest there is only two...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
0.007(7.14%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 10.5¢ | 9.5¢ | $8.154K | 83.09K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5102 | 9.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 124847 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |